{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T03:02:57Z","timestamp":1794452577162,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T00:00:00Z","timestamp":1586822400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Malignant melanoma is a fatal disease that rapidly spreads to the whole body. Treatments have limited efficiency owing to drug resistance and various side effects. <jats:italic>Pseudomonas syringae<\/jats:italic> pv. <jats:italic>tomato<\/jats:italic> (<jats:italic>Pto<\/jats:italic>) is a model bacterial pathogen capable of systemic infection in plants. <jats:italic>Pto<\/jats:italic> injects the effector protein HopQ into the plant cytosol via a type III secretion machinery and suppresses the host immunity. Intriguingly, host plant proteins regulated by HopQ are conserved even in humans and conferred in tumor metastasis. Nevertheless, the potential for HopQ to regulate human cancer metastasis was unknown. In this study, we addressed the suitability of HopQ as a possible drug against melanoma metastasis. In melanoma cells, overexpressed HopQ is phosphorylated and bound to 14-3-3 through its N-terminal domain, resulting in stronger interaction between HopQ and vimentin. The binding of HopQ to vimentin allowed for degradation of vimentin via p62-dependent selective autophagy. Attenuation of vimentin expression by HopQ inhibited melanoma motility and in vivo metastasis. These findings demonstrated that HopQ directly degraded vimentin in melanoma cells and could be applied to an inhibitor of melanoma metastasis.<\/jats:p>","DOI":"10.1038\/s41419-020-2427-y","type":"journal-article","created":{"date-parts":[[2020,4,14]],"date-time":"2020-04-14T13:02:45Z","timestamp":1586869365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Bacterial type III effector protein HopQ inhibits melanoma motility through autophagic degradation of vimentin"],"prefix":"10.1038","volume":"11","author":[{"given":"Seung-Ho","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Jin","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0001-6646","authenticated-orcid":false,"given":"Jun-Seob","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moo-Seung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Ki","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7590-8812","authenticated-orcid":false,"given":"Mi-Young","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7276-1189","authenticated-orcid":false,"given":"Choong-Min","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyun","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Jun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,14]]},"reference":[{"key":"2427_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrclinonc.2013.246","volume":"11","author":"D Schadendorf","year":"2014","unstructured":"Schadendorf, D. & Hauschild, A. Melanoma in 2013: melanoma-the run of success continues. Nat. Rev. Clin. Oncol. 11, 75\u201376 (2014).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"2427_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3529-5","volume":"17","author":"MV Heppt","year":"2017","unstructured":"Heppt, M. V. et al. Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care. BMC cancer 17, 536 (2017).","journal-title":"BMC cancer"},{"key":"2427_CR3","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252\u2013264 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"2427_CR4","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1158\/2159-8290.CD-13-0642","volume":"4","author":"H Shi","year":"2014","unstructured":"Shi, H. et al. Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy. Cancer Discov. 4, 80\u201393 (2014).","journal-title":"Cancer Discov."},{"key":"2427_CR5","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/nature13954","volume":"515","author":"PC Tumeh","year":"2014","unstructured":"Tumeh, P. C. et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515, 568\u2013571 (2014).","journal-title":"Nature"},{"key":"2427_CR6","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/bjd.15348","volume":"177","author":"JH Wu","year":"2017","unstructured":"Wu, J. H., Cohen, D. N., Rady, P. L. & Tyring, S. K. BRAF inhibitor-associated cutaneous squamous cell carcinoma: new mechanistic insight, emerging evidence for viral involvement and perspectives on clinical management. Br. J. Dermatol. 177, 914\u2013923 (2017).","journal-title":"Br. J. Dermatol."},{"key":"2427_CR7","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1126\/science.1171647","volume":"324","author":"T Boller","year":"2009","unstructured":"Boller, T. & He, S. Y. Innate immunity in plants: an arms race between pattern recognition receptors in plants and effectors in microbial pathogens. Science 324, 742\u2013744 (2009).","journal-title":"Science"},{"key":"2427_CR8","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1146\/annurev-phyto-082712-102321","volume":"51","author":"XF Xin","year":"2013","unstructured":"Xin, X. F. & He, S. Y. Pseudomonas syringae pv. tomato DC3000: a model pathogen for probing disease susceptibility and hormone signaling in plants. Annu. Rev. Phytopathol. 51, 473\u2013498 (2013).","journal-title":"Annu. Rev. Phytopathol."},{"key":"2427_CR9","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1146\/annurev.arplant.56.032604.144218","volume":"56","author":"MB Mudgett","year":"2005","unstructured":"Mudgett, M. B. New insights to the function of phytopathogenic bacterial type III effectors in plants. Annu. Rev. Plant Biol. 56, 509\u2013531 (2005).","journal-title":"Annu. Rev. Plant Biol."},{"key":"2427_CR10","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1104\/pp.112.209023","volume":"161","author":"F Giska","year":"2013","unstructured":"Giska, F. et al. Phosphorylation of HopQ1, a type III effector from Pseudomonas syringae, creates a binding site for host 14-3-3 proteins. Plant Physiol. 161, 2049\u20132061 (2013).","journal-title":"Plant Physiol."},{"key":"2427_CR11","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1104\/pp.112.211748","volume":"161","author":"W Li","year":"2013","unstructured":"Li, W., Yadeta, K. A., Elmore, J. M. & Coaker, G. The Pseudomonas syringae effector HopQ1 promotes bacterial virulence and interacts with tomato 14-3-3 proteins in a phosphorylation-dependent manner. Plant Physiol. 161, 2062\u20132074 (2013).","journal-title":"Plant Physiol."},{"key":"2427_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.tcb.2008.10.003","volume":"19","author":"DK Morrison","year":"2009","unstructured":"Morrison, D. K. The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol. 19, 16\u201323 (2009).","journal-title":"Trends Cell Biol."},{"key":"2427_CR13","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.semcdb.2011.08.009","volume":"22","author":"AK Freeman","year":"2011","unstructured":"Freeman, A. K. & Morrison, D. K. 14-3-3 Proteins: diverse functions in cell proliferation and cancer progression. Semin. Cell Dev. Biol. 22, 681\u2013687 (2011).","journal-title":"Semin. Cell Dev. Biol."},{"key":"2427_CR14","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1172\/JCI38339","volume":"119","author":"JE Eriksson","year":"2009","unstructured":"Eriksson, J. E. et al. Introducing intermediate filaments: from discovery to disease. J. Clin. Invest. 119, 1763\u20131771 (2009).","journal-title":"J. Clin. Invest."},{"key":"2427_CR15","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1016\/j.yexcr.2007.03.040","volume":"313","author":"J Ivaska","year":"2007","unstructured":"Ivaska, J., Pallari, H. M., Nevo, J. & Eriksson, J. E. Novel functions of vimentin in cell adhesion, migration, and signaling. Exp. Cell Res. 313, 2050\u20132062 (2007).","journal-title":"Exp. Cell Res."},{"key":"2427_CR16","first-page":"327","volume":"28","author":"J Wei","year":"2008","unstructured":"Wei, J. et al. Overexpression of vimentin contributes to prostate cancer invasion and metastasis via src regulation. Anticancer Res. 28, 327\u2013334 (2008).","journal-title":"Anticancer Res."},{"key":"2427_CR17","first-page":"5239","volume":"30","author":"Y Fuyuhiro","year":"2010","unstructured":"Fuyuhiro, Y. et al. Clinical significance of vimentin-positive gastric cancer cells. Anticancer Res. 30, 5239\u20135243 (2010).","journal-title":"Anticancer Res."},{"key":"2427_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/path.1797","volume":"206","author":"E Korsching","year":"2005","unstructured":"Korsching, E. et al. The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential? J. Pathol. 206, 451\u2013457 (2005).","journal-title":"J. Pathol."},{"key":"2427_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1165\/rcmb.2013-0314TR","volume":"50","author":"ME Kidd","year":"2014","unstructured":"Kidd, M. E., Shumaker, D. K. & Ridge, K. M. The role of vimentin intermediate filaments in the progression of lung cancer. AM J. Resp. Cell Mol. 50, 1\u20136 (2014).","journal-title":"AM J. Resp. Cell Mol."},{"key":"2427_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00627007","volume":"400","author":"J Caselitz","year":"1983","unstructured":"Caselitz, J., Janner, M., Breitbart, E., Weber, K. & Osborn, M. Malignant melanomas contain only the vimentin type of intermediate filaments. Virchows Arch. 400, 43\u201351 (1983).","journal-title":"Virchows Arch."},{"key":"2427_CR21","doi-asserted-by":"publisher","first-page":"3033","DOI":"10.1007\/s00018-011-0735-1","volume":"68","author":"A Satelli","year":"2011","unstructured":"Satelli, A. & Li, S. Vimentin in cancer and its potential as a molecular target for cancer therapy. Cell. Mol. Life Sci. 68, 3033\u20133046 (2011).","journal-title":"Cell. Mol. Life Sci."},{"key":"2427_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1756-9966-29-109","volume":"29","author":"M Li","year":"2010","unstructured":"Li, M. et al. A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis. J. Exp. Clin. Canc. Res. 29, 109 (2010).","journal-title":"J. Exp. Clin. Canc. Res."},{"key":"2427_CR23","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.1111\/1462-2920.14426","volume":"20","author":"SJ Yoon","year":"2018","unstructured":"Yoon, S. J. et al. Pseudomonas syringae evades phagocytosis by animal cells via type III effector-mediated regulation of actin filament plasticity. Environ. Microbiol. 20, 3980\u20133991 (2018).","journal-title":"Environ. Microbiol."},{"key":"2427_CR24","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1002\/jcp.26114","volume":"233","author":"L Zhao","year":"2018","unstructured":"Zhao, L., Zhang, P., Su, X. J. & Zhang, B. The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin. J. Cell Physiol. 233, 2420\u20132425 (2018).","journal-title":"J. Cell Physiol."},{"key":"2427_CR25","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/sj.cdd.4400840","volume":"8","author":"Y Byun","year":"2001","unstructured":"Byun, Y. et al. Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis. Cell Death Differ. 8, 443\u2013450 (2001).","journal-title":"Cell Death Differ."},{"key":"2427_CR26","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.cell.2010.01.028","volume":"140","author":"N Mizushima","year":"2010","unstructured":"Mizushima, N., Yoshimori, T. & Levine, B. Methods in mammalian autophagy research. Cell 140, 313\u2013326 (2010).","journal-title":"Cell"},{"key":"2427_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/s41556-018-0037-z","volume":"20","author":"D Gatica","year":"2018","unstructured":"Gatica, D., Lahiri, V. & Klionsky, D. J. Cargo recognition and degradation by selective autophagy. Nat. Cell Biol. 20, 233\u2013242 (2018).","journal-title":"Nat. Cell Biol."},{"key":"2427_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000051","volume":"16","author":"P Tan","year":"2018","unstructured":"Tan, P. et al. TRIM59 promotes breast cancer motility by suppressing p62-selective autophagic degradation of PDCD10. PLoS Biol. 16, e3000051 (2018).","journal-title":"PLoS Biol."},{"key":"2427_CR29","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1016\/j.celrep.2016.07.019","volume":"16","author":"T Liu","year":"2016","unstructured":"Liu, T. et al. TRIM11 suppresses AIM2 inflammasome by degrading AIM2 via p62-dependent selective autophagy. Cell Rep. 16, 1988\u20132002 (2016).","journal-title":"Cell Rep."},{"key":"2427_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003196","volume":"9","author":"J Zhou","year":"2013","unstructured":"Zhou, J. et al. NBR1-mediated selective autophagy targets insoluble ubiquitinated protein aggregates in plant stress responses. PLoS Genet. 9, e1003196 (2013).","journal-title":"PLoS Genet."},{"key":"2427_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ccr.2014.05.015","volume":"26","author":"Z Liu","year":"2014","unstructured":"Liu, Z. et al. Ubiquitylation of autophagy receptor Optineurin by HACE1 activates selective autophagy for tumor suppression. Cancer Cell. 26, 106\u2013120 (2014).","journal-title":"Cancer Cell."},{"key":"2427_CR32","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.devcel.2014.06.013","volume":"30","author":"MA Mandell","year":"2014","unstructured":"Mandell, M. A. et al. TRIM proteins regulate autophagy and can target autophagic substrates by direct recognition. Dev. Cell. 30, 394\u2013409 (2014).","journal-title":"Dev. Cell."},{"key":"2427_CR33","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1105\/tpc.17.00815","volume":"30","author":"S Ustun","year":"2018","unstructured":"Ustun, S. et al. Bacteria exploit autophagy for proteasome degradation and enhanced virulence in plants. Plant Cell. 30, 668\u2013685 (2018).","journal-title":"Plant Cell."},{"key":"2427_CR34","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1093\/carcin\/bgx099","volume":"38","author":"SS Li","year":"2017","unstructured":"Li, S. S. et al. p62\/SQSTM1 interacts with vimentin to enhance breast cancer metastasis. Carcinogenesis 38, 1092\u20131103 (2017).","journal-title":"Carcinogenesis"},{"key":"2427_CR35","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1021\/acs.molpharmaceut.5b00377","volume":"13","author":"L Herrera Estrada","year":"2016","unstructured":"Herrera Estrada, L., Padmore, T. J. & Champion, J. A. Bacterial effector nanoparticles as breast cancer therapeutics. Mol. Pharm. 13, 710\u2013719 (2016).","journal-title":"Mol. Pharm."},{"key":"2427_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nm.3984","volume":"22","author":"N Andor","year":"2016","unstructured":"Andor, N. et al. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity. Nat. Med. 22, 105\u2013113 (2016).","journal-title":"Nat. Med."},{"key":"2427_CR37","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41568-019-0154-4","volume":"19","author":"I Arozarena","year":"2019","unstructured":"Arozarena, I. & Wellbrock, C. Phenotype plasticity as enabler of melanoma progression and therapy resistance. Nat. Rev. Cancer 19, 377\u2013391 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"2427_CR38","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnam","year":"2018","unstructured":"Gopalakrishnam, V. et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359, 97\u2013103 (2018).","journal-title":"Science"},{"key":"2427_CR39","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","volume":"359","author":"V Matson","year":"2018","unstructured":"Matson, V. et al. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science 359, 104\u2013108 (2018).","journal-title":"Science"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2427-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2427-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2427-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:54:58Z","timestamp":1670252098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2427-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,14]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4]]}},"alternative-id":["2427"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2427-y","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,14]]},"assertion":[{"value":"4 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"231"}}